Comment on spironolactone, but not flutamide, administration prevents boneloss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist
J. Prezelj et A. Kocijancic, Comment on spironolactone, but not flutamide, administration prevents boneloss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist, J CLIN END, 84(12), 1999, pp. 4747-4747